Downregulation of SATB2 in patients with GC was associated with shortened survival and, in the gastric cancer cell line MGC-803, the overexpression of SATB2 was able to repress ERK5 expression, while activation of ERK5 restored the SATB2-induced inhibition of proliferation and migration [26,27]. The gene discussed is MAPK7; the disease is gastric cancer.